|
|
|
||||||||||
|
University of Zurich, Universitätsspital Zürich
Phone: +41 44 255 97 53 |
MY PROJECT
Nonalcoholic fatty liver disease (NAFLD) is a very frequent liver disease encompassing a range of diagnoses, from mild fatty infiltration, steatohepatitis (NASH) and cirrhosis. NAFLD is of rising clinical relevance due to increased prevalence of the metabolic syndrome and diabetes mellitus. We aim to elucidate molecular mechanisms leading to hepatic insulin resistance and fatty liver disease by analysing genetically modified mice and liver biopsies of patients suffering from NAFLD/NASH.
I am a member of the Giatgen Spinas group.
Wichtiger Hinweis:
Diese Website wird in älteren Versionen von Netscape ohne
graphische Elemente dargestellt. Die Funktionalität der
Website ist aber trotzdem gewährleistet. Wenn Sie diese
Website regelmässig benutzen, empfehlen wir Ihnen, auf
Ihrem Computer einen aktuellen Browser zu installieren. Weitere
Informationen finden Sie auf
folgender
Seite.
Important Note:
The content in this site is accessible to any browser or
Internet device, however, some graphics will display correctly
only in the newer versions of Netscape. To get the most out of
our site we suggest you upgrade to a newer browser.
More
information